Post listing view on Supriya Lifescience IPO By Mr. Santosh Meena, Swastika Investmart Ltd

28/12/2021 12:21:16 PM | Source: Swastika Investmart Ltd

Post listing view on Supriya Lifescience IPO By Mr. Santosh Meena, Swastika Investmart Ltd

News By Tags | #607 #442 #5503 #7106 #2911

Below is the Post listing view on Supriya Lifescience IPO by Mr. Santosh Meena, Head of Research, Swastika Investmart Ltd

In the last 3-5 years, the API and specialty chemical industry have been darling for investors, and we believe that this trend will continue for several years. As a result of the decent participation from investors, the IPO debuted at Rs 421 versus the issue price of Rs 274, a premium of 53%. In the long run, investors should hold the stock while those who applied for listing gains can keep a stop loss of Rs 380 on a closing basis. New investors can also look for buying opportunities in dips.

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here

IGI Logo

Post listing view on Supriya Lifescience IPO By Mr. Santosh Meena, Swastika Investmart Ltd

Top News

Tag News

More News